BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 16, 2016
View Archived Issues
Argos Therapeutics and Personalis enter research agreement
Read More
BlueRock obtains sublicense to cardiac stem cell technologies from VistaGen
Read More
Mersana begins first-in-human study of XMT-1522 in breast cancer and HER2-expressing cancers
Read More
Nanobiotix's NBTXR-3 shows positive results in phase I/II study in liver cancer
Read More
Basaglar becomes available in the U.S.
Read More
IRL patents cortical cathecolaminergic neurotransmission modulators
Read More
Roche terminates agreement with Pacific Biosciences
Read More
Clinical cancer candidate CYC-140 shows antiproliferative activity
Read More
RespireRx Pharmaceuticals' CX-1739 safe, well-tolerated in phase IIa study
Read More
Kyorin Pharmaceutical discloses FPR2 agonists
Read More
Merck & Co. describes HIV integrase inhibitors
Read More
Redx Pharma develops antibacterial agents
Read More
Amgen describes BiTE antibody targeting EGFR, CD3
Read More
Aurigene Discovery Technologies presents CDK inhibitors
Read More
OrthoTrophix's TPX-100 improves knee function in phase II study in knee osteoarthritis
Read More
Phase I dose-escalation study results for DS-3032b
Read More
Target ALS Foundation gives Karyopharm grant supporting KPT-350 research
Read More
FDA clears IND for phase I trials of CER-209 for NASH and NAFLD
Read More
Poziotinib shows efficacy in a model harboring insertions in exon 20 of EGFR
Read More
Noxxon Pharma enters agreement to study NOX-A12 with pembrolizumab
Read More
EMA grants orphan designation to REGN-2477 for fibrodysplasia ossificans progressiva
Read More
Takara Bio and Otsuka sign exclusive license agreement for the oncolytic virus HF10 in Japan
Read More
Evotec and Celgene form drug discovery and development collaboration in neurodegenerative diseases
Read More
Novartis to acquire Ziarco
Read More
SKLB-518 shows promise to overcome drug-resistant mutations of Bcr-Abl1
Read More
CFDA grants approval for clinical trials of fadanafil
Read More
Agios discontinues development of AG-519
Read More
Medgenics changes name
Read More